WOMEN'S ROGAINE FOAM 5% 5 %
MINOXIDIL : 5 % · DIN 02424703 · JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is WOMEN'S ROGAINE FOAM 5%?
WOMEN'S ROGAINE FOAM 5% 5 % contains MINOXIDIL : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02424703, held by JOHNSON & JOHNSON INC, supplied as AEROSOL, FOAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 24-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is WOMEN'S ROGAINE FOAM 5% used for?
Treatment of androgenetic alopecia (male/female pattern hair loss) on the top of the scalp (vertex). Effectiveness on receding hairlines not demonstrated.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02424703 |
|---|---|
| Brand name | WOMEN'S ROGAINE FOAM 5% |
| Generic / active ingredient | MINOXIDIL : 5 % |
| Manufacturer | JOHNSON & JOHNSON INC |
| Strength | 5 % |
| Dosage form | AEROSOL, FOAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AX01 MINOXIDIL, TOPICAL |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Dec-2025 |
How is it administered?
Solution: 1 mL twice daily. Men's Foam: 1/2 capful twice daily. Women's Foam: 1/2 capful once daily. Apply to dry scalp. Wash hands after use. Do not exceed recommended daily dose.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly stated in the provided text (refer to section 11 in full monograph).
How is it supplied?
Solution: 60 mL bottle with child-resistant dropper. Foam: 60 g aluminum pressurized container with child-resistant cap (packs of 1, 2, or 3 cans).
Contraindications
Pregnant/breastfeeding women; history of hypersensitivity to minoxidil; treated/untreated hypertension; non-hereditary hair loss; scalp abnormalities (psoriasis, sunburn, broken/inflamed skin).
Warnings and precautions
For external use only. Avoid contact with eyes/mucous membranes. Stop use if chest pain, rapid heartbeat, faintness, dizziness, or sudden weight gain occurs. May change hair color/texture.
What can be used instead?
Other Canadian products sharing ATC code D11AX01 MINOXIDIL, TOPICAL. 7 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HAIR REGROWTH FORMULA | 20 MG | SOLUTION | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02356597 |
| MEN'S GLN-MINOXIDIL | 5 % | AEROSOL, FOAM | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02553465 |
| MEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02551446 |
| MEN'S ROGAINE | 20 MG | SOLUTION | JOHNSON & JOHNSON INC | MARKETED | DIN 00708925 |
| MEN'S ROGAINE FOAM 5% | 5 % | AEROSOL, FOAM | JOHNSON & JOHNSON INC | MARKETED | DIN 02368684 |
| WOMEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02551659 |
| APO-GAIN LIQ 20MG/ML | 20 MG | SOLUTION | APOTEX INC | DORMANT | DIN 00885754 |
| GEN-MINOXIDIL LIQ 2% | 2 % | LIQUID | GENPHARM ULC | CANCELLED POST MARKET | DIN 02065800 |
| HAIR REGROWTH TREATMENT | 2 % | SOLUTION | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 02242377 |
| HAIR REGROWTH TREATMENT | 2 % | SOLUTION | APOTEX INC | APPROVED | DIN 02460181 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.